Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia
Authors:
Open Access
- 18 January 2022
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (2) , 509-514
Abstract
Cholesterol homeostasis has been proposed as one mechanism contributing to chemoresistance in AML and hence, inclusion of statins in therapeutic regimens as part of clinical trials in AML has shown encouraging results. Chemical screening of primary human AML specimens by our group led to the identification of lipophilic statins as potent inhibitors of AMLs from a wide range of cytogenetic groups. Genetic screening to identify modulators of the statin response uncovered the role of protein geranylgeranylation and of RAB proteins, coordinating various aspect of vesicular trafficking, in mediating the effects of statins on AML cell viability. We further show that statins can inhibit vesicle-mediated transport in primary human specimens, and that statins sensitive samples show expression signatures reminiscent of enhanced vesicular trafficking. Overall, this study sheds light into the mechanism of action of statins in AML and identifies a novel vulnerability for cytogenetically diverse AML.Keywords
This publication has 22 references indexed in Scilit:
- SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaBritish Journal of Haematology, 2014
- Identification of small molecules that support human leukemia stem cell activity ex vivoNature Methods, 2014
- Controlling Cholesterol Synthesis beyond 3-Hydroxy-3-methylglutaryl-CoA Reductase (HMGCR)Journal of Biological Chemistry, 2013
- Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patientsExperimental Hematology, 2012
- A novel statin-mediated “prenylation block-and-release” assay provides insight into the membrane targeting mechanisms of small GTPasesBiochemical and Biophysical Research Communications, 2010
- Rab GTPases as coordinators of vesicle trafficNature Reviews Molecular Cell Biology, 2009
- Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 studyBlood, 2006
- Chemical, pharmacokinetic and pharmacodynamic properties of statins: an updateFundamental & Clinical Pharmacology, 2004
- Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cellsBlood, 2004
- Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responsesBlood, 2003